THE ENCLOSED SLIDES ARE FREE FOR PUBLIC USE

DECEMBER 2015

ACHP Drug Cost Chart Pack

The Spike in Drug Costs

Advancements in pharmaceuticals can result in drugs that offer fewer side effects, improve a patient’s quality of life and

save lives, but what if not everyone can afford them?

THERE’S ENORMOUS PRESSURE ON…..

Consumers andtheir families, whomay be faced withthe difficult choicebetween paying for

MS medications and other necessities.

Employers, who may be forced to make cuts to their

overall benefits package in order to fund rising health

care costs.

Health care providers, who treat an increase in

disease-related complications due in part

to non-adherence to costly medications.

Health plans andother payers, who

want to ensure people get the right

drugs and keep coverage affordable.

Federal government,which is bearingan ever-growing

share of the costs ofthese drugs, placing

increasing pressure on the federal budget.

The Spike in Drug Costs: Diabetes

GENERAL STATISTICS:

1 in 11 people in the U.S. has diagnosed or

undiagnosed diabetes. This is expected to increase to

1 in 3 people by 2050.

The cost of diagnosed diabetes

in 2012 was $245 billion.

The Spike in Drug Costs: Diabetes

Primarily because of escalating drug costs, spending on insulin and

other diabetes medications is expected to rise 18.3 percent over the next three years, a rate of increase 60 times greater than the recent income growth average of just 0.3 percent

across all households.

The Spike in Drug Costs: Diabetes

5

Diabetes Drugs with Significant Percent Price Changes Over Five Years(3/1/2010 – 2/28/2015)

Source: Medi-Span® Price Rx®. Figures reflect wholesale acquisition cost.Note: Price modifications will alter the values reflected above.

The Spike in Drug Costs: Multiple SclerosisGENERAL STATISTICS:

Multiple Sclerosis (MS) affects at least 400,000 people in the

United States and more than 2.5 million globally.

MS drugs help people manage their condition and enhance

their comfort and quality of life.

The cost of taking MS drugscan span a lifetime.

There is currently no cure for MS.

The Spike in Drug Costs:Multiple Sclerosis

Lemtrada, approved for sale in the U.S. in 2014, has a two-year course of treatment estimated at $158,000.

The Spike in Drug Costs: Multiple Sclerosis

8

MS Drugs with the Highest % Price Changes Since Launch for a 30-Day Supply

*Date listed is the first instance of available pricing data in Medi-Span®Price Rx®. The true launch date is earlier than that listed.Source: Medi-Span® Price Rx® and www.rxlist.com. Figures reflectwholesale acquisition cost.Note: Price modifications will alter the values reflected above.

The Spike in Drug Costs:Multiple Sclerosis

First-generation MS drugs, originally costing $8,000 - $11,000 per year, can now exceed $60,000 per person per year.

The Spike in Drug Costs:Multiple Sclerosis

The Spike in Drug Costs:Multiple Sclerosis

The new 40 mg dose of the widely prescribed drug Copaxone costs $5,0086 a month, yet shows no gain in efficacy over

the 20 mg dose.